Which Stock is better? American Express Company (AXP) and Astrazeneca PLC (AZN)

The shares of American Express Company (NYSE:AXP) and Astrazeneca PLC (NYSE:AZN) were among the active stocks of the last trading sessions. American Express Company (NYSE:AXP) declined to -1.92% closing at the price of $101.58 whereas the shares of Astrazeneca PLC (NYSE:AZN) declined -1.08% with the decrease of -0.41 points closing at the price of $37.64. American Express Company has currently increase 9.19% in its stock over the period of 6-months while its rival Astrazeneca PLC added 3.63% in the previous 6-months.

Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.

Returns and Profitability

Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.

The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of American Express Company (NYSE:AXP) is 3.7% while the ROI of Astrazeneca PLC (NYSE:AZN) is 13.3%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, AXP’s EBITDA Margin is NOT AVAILABLE whereas AZN’s is 25.63.

Both the profitability ratios suggest a mixed sentiment for American Express Company (NYSE:AXP) and Astrazeneca PLC (NYSE:AZN).

EPS & Surprise Factor

American Express Company (NYSE:AXP) reported $1.84/share EPS for the previous quarter where analysts were predicting an EPS to be $1.82/share Thus beating the analyst Estimates with a Surprise Factor of 1.1 Percent. While, Astrazeneca PLC (NYSE:AZN) reported EPS of $0.35/share in the last quarter. The analysts projected EPS of $0.3/share depicting a Surprise of 16.7 Percent.

Taking a look at Earnings per Share, Astrazeneca PLC tends to be beating the analyst estimates more than American Express Company. so AZN is more profitable than AXP.

Technical Analysis of American Express Company & Astrazeneca PLC

Moving average convergence divergence (MACD) shows that American Express Company (NYSE:AXP) is on a PRICE RELATIVITY trend While Astrazeneca PLC (NYSE:AZN) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the American Express Company was in BEARISH territory and Astrazeneca PLC was in BEARISH territory.

AXP’s current statistics gauge that the stock candle is BEARISH with HIGH volatility. While AZN’s candle is BEARISH with HIGH.

EPS Growth Rate: AXP’s 11.8% versus AZN’s 12.5%

Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of American Express Company (NYSE:AXP) is predicted at 11.8% while Astrazeneca PLC (NYSE:AZN) stands at 12.5%. These numbers suggest that AZN is more suitable investment in terms of EPS growth rate.

Financial Risk and Liquidity Concerns

The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of AXP stands at 0 while AZN is at 0.7 whereas the debt ratio of the prior is 5.99 while the debt ratio of the later is 1.56.

The values of the both ratios suggest that one is more liquid and other investment is more risk free.

Analyst Recommendations

While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.3 for AXP and 1.6 for AZN which means AXP has Hold rating whereas AZN has Buy rating.

Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for AXP is $114.27 which is 11.11% of its current price while AZN has price target of 41.66 which is 9.65% of its current price.

Valuation Ratios

Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.

AXP currently has price to earning P/E ratio of 14.9 whereas AZN has 35.28 while the forward P/E ratio for the prior stands at 12.64 and for the later it depicts the value of 20.02.

The price to Book P/B for AXP is 4.18, Price to Sale is at 2.31 and for AZN these ratios stand at 7.54 and 4.27.